Latest News - Allergan

Thursday, March 16, 2017 | Blindness, Partnerships, Allergan, Prevent Blindness

Prevent Blindness and Allergan Work Together Through 'See America' to Promote Healthy Vision

Prevent Blindness, the nation’s oldest volunteer eye health and safety group, and Allergan, a global leader in eye care for nearly 70 years, have embarked on a joint effort to promote healthy vi…

Read the full story

Tuesday, March 14, 2017 | Product Releases, Allergan

USC Roski Eye Institute Ophthalmologists Are First to Use XEN Gel Stent to Treat Glaucoma Patients in Los Angeles

The University of Southern California (USC) Roski Eye Institute became the first team in Los Angeles county to implant the XEN gel stent in glaucoma patients on March 9, 2017. The XEN gel stent w…

Read the full story

Tuesday, March 14, 2017 | Miscellaneous, Allergan

Award Winning Actor And Hip-Hop Artist Common Joins Allergan's 'See America' Initiative To Further The Fight Against Preventable Blindness

See America, Allergan's initiative to fight against preventable blindness in the United States, unveiled a video featuring award-winning actor and hip-hop artist Common that urges Americans to &qu…

Read the full story

Tuesday, March 14, 2017 | Acquisitions/Mergers, Allergan

Allergan and Editas Medicine Enter Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases

Allergan and Editas Medicine, a genome editing company, announced that Allergan's wholly owned subsidiary, Allergan Pharmaceuticals International Limited, and Editas Medicine have entered into a s…

Read the full story

Thursday, February 23, 2017 | Health Care, Allergan

Allergan CEO Pushes for Trump to Lead Drug Price Discussions

When asked about President Trump’s calls to deal with high US drug costs, Allergan Chief Executive Officer Brent Saunders told Bloomberg News that President Trump should lead negotiations with d…

Read the full story

Tuesday, February 14, 2017 | Glaucoma, Allergan, MIGS

Allergan Announces First Commercial Use of XEN Glaucoma Treatment System in the US

Allergan announced that its XEN Glaucoma Treatment System is now being used by US surgeons to treat refractory glaucoma. The XEN Glaucoma Treatment System, consisting of the XEN45 Gel Stent and the XE…

Read the full story

Monday, February 13, 2017 | Acquisitions/Mergers, Allergan

Allergan to Acquire Zeltiq, Maker of CoolSculpting System, for $2.47 Billion

Allergan has agreed to acquire Zeltiq Aesthetics for $56.50 per share, or $2.475 billion, subject to customary adjustments, the companies announced in a news release. T Allergan said the acquisitio…

Read the full story

Tuesday, February 07, 2017 | Partnerships, Allergan

Allergan Launches 'See America,' an Initiative Furthering the Fight Against Preventable Blindness

Allergan announced a commitment to fight preventable blindness in the United States with a new initiative -- See America. Through See America, Allergan sets out to make vision health a priority for al…

Read the full story

Thursday, December 22, 2016 | Management/Leadership, Allergan

Allergan’s CEO Has Struck an Insane Number of Biotech Deals

Allergan chief Brent Saunders has had a pretty remarkable career trajectory. He headed up Bausch & Lomb until the eye care specialist was snatched up by the (now-infamous) Valeant Pharmaceuticals;…

Read the full story

Wednesday, December 21, 2016 | Acquisitions/Mergers, Allergan

Allergan to Acquire Acelity LifeCell Corporation for $2.9 Billion

Allergan and Acelity announced that they have entered into a definitive agreement under which Allergan has agreed to acquire the regenerative medicine company LifeCell for $2.9 billion in cash. The…

Read the full story

Friday, December 02, 2016 | Health Care, Allergan

Allergan CEO: 'I Worry Today that Pharma has a False Sense of Relief or Security' with Trump Presidency

Investors betting that Donald Trump is going to lay off the drug industry might be in for a surprise, according to the CEO of Botox maker Allergan. Drug stocks have were among the biggest gainers in t…

Read the full story

Tuesday, November 22, 2016 | FDA Approval/Clearance, Product Releases, Allergan, MIGS

Allergan Receives FDA Clearance for the XEN Gel Stent, a New Surgical Treatment for Refractory Glaucoma

Allergan announced that the FDA has cleared the XEN Glaucoma Treatment System, which consists of the XEN45 Gel Stent and the XEN Injector. The XEN Glaucoma Treatment System reduces IOP in patients and…

Read the full story

Thursday, November 10, 2016 | Medical Studies, Allergan

New Report Explores Divide Between Managed Care and Eye Care Professionals

The Eye Care Trend Report, Volume II, supported by Allergan, is now available. The award-winning, 40-page report examines and compares the perspectives of managed care organizations (MCOs), ophthalmol…

Read the full story

Thursday, November 03, 2016 | Earnings & Financials, Allergan

Allergan Initiates Dividend and Expands Stock Buyback as It Eschews Megadeals

Allergan PLC on Wednesday lowered its outlook, saying sales of some drugs were weaker than expected. The company also said it would return more cash to shareholders because the drugmaker isn’t i…

Read the full story

Friday, October 28, 2016 | Product Releases, Allergan

Allergan Introduces Preservative-Free Restasis Multidose

Allergan announced that it has received approval from the FDA for Restasis Multidose (cyclosporine ophthalmic emulsion) 0.05%, a preservative-free, multidose bottle offering the same preservative…

Read the full story
Load More